We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Form 483 to Biogen Idec Cites Supplier Quality Management Issues
FDA Form 483 to Biogen Idec Cites Supplier Quality Management Issues
The FDA issued a Form 483 to Biogen Idec that cites a weakness in the way the company manages suppliers, highlighting the difficulties drugmakers continue to have with supplier quality issues.